Brachytherapy for locally recurrent soft-tissue sarcoma

Nora Janjan, Christopher Crane, Marc Delclos, Matthew Ballo

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Radiation is used to reduce potential risk of local recurrence from microscopic residual disease after surgical resection. Brachytherapy is a clinically established means of providing radiation for soft-tissue sarcomas that recur after surgical resection alone or surgical resection and radiation. Although the total dose of radiation that is prescribed is approximately the same for patients undergoing external beam radiation or brachytherapy, the radiobiologic characteristics of brachytherapy, based on the inverse-square law, provide higher doses of radiation to the surgical bed. This provides a theoretical advantage for the use of brachytherapy as compared with external beam radiation among patients with recurrence after surgical resection. When soft-tissue sarcomas recur in a previously irradiated area, further external beam radiation generally is not possible; therefore, brachytherapy allows a radiotherapeutic alternative in an attempt to reduce the risk of further local recurrence. Recommendations for patient selection, the total dose of radiation, and the radiation dose-rate are outlined. Standard grading systems for response, symptoms, and severity of complications should be used.

Original languageEnglish (US)
Pages (from-to)9-15
Number of pages7
JournalAmerican Journal of Clinical Oncology: Cancer Clinical Trials
Volume25
Issue number1
DOIs
StatePublished - Feb 18 2002
Externally publishedYes

Fingerprint

Brachytherapy
Sarcoma
Radiation
Recurrence
Patient Selection

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Brachytherapy for locally recurrent soft-tissue sarcoma. / Janjan, Nora; Crane, Christopher; Delclos, Marc; Ballo, Matthew.

In: American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 25, No. 1, 18.02.2002, p. 9-15.

Research output: Contribution to journalArticle

Janjan, Nora ; Crane, Christopher ; Delclos, Marc ; Ballo, Matthew. / Brachytherapy for locally recurrent soft-tissue sarcoma. In: American Journal of Clinical Oncology: Cancer Clinical Trials. 2002 ; Vol. 25, No. 1. pp. 9-15.
@article{4cf158b321c746f4a41f39a6caa2d07c,
title = "Brachytherapy for locally recurrent soft-tissue sarcoma",
abstract = "Radiation is used to reduce potential risk of local recurrence from microscopic residual disease after surgical resection. Brachytherapy is a clinically established means of providing radiation for soft-tissue sarcomas that recur after surgical resection alone or surgical resection and radiation. Although the total dose of radiation that is prescribed is approximately the same for patients undergoing external beam radiation or brachytherapy, the radiobiologic characteristics of brachytherapy, based on the inverse-square law, provide higher doses of radiation to the surgical bed. This provides a theoretical advantage for the use of brachytherapy as compared with external beam radiation among patients with recurrence after surgical resection. When soft-tissue sarcomas recur in a previously irradiated area, further external beam radiation generally is not possible; therefore, brachytherapy allows a radiotherapeutic alternative in an attempt to reduce the risk of further local recurrence. Recommendations for patient selection, the total dose of radiation, and the radiation dose-rate are outlined. Standard grading systems for response, symptoms, and severity of complications should be used.",
author = "Nora Janjan and Christopher Crane and Marc Delclos and Matthew Ballo",
year = "2002",
month = "2",
day = "18",
doi = "10.1097/00000421-200202000-00002",
language = "English (US)",
volume = "25",
pages = "9--15",
journal = "American Journal of Clinical Oncology",
issn = "0277-3732",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Brachytherapy for locally recurrent soft-tissue sarcoma

AU - Janjan, Nora

AU - Crane, Christopher

AU - Delclos, Marc

AU - Ballo, Matthew

PY - 2002/2/18

Y1 - 2002/2/18

N2 - Radiation is used to reduce potential risk of local recurrence from microscopic residual disease after surgical resection. Brachytherapy is a clinically established means of providing radiation for soft-tissue sarcomas that recur after surgical resection alone or surgical resection and radiation. Although the total dose of radiation that is prescribed is approximately the same for patients undergoing external beam radiation or brachytherapy, the radiobiologic characteristics of brachytherapy, based on the inverse-square law, provide higher doses of radiation to the surgical bed. This provides a theoretical advantage for the use of brachytherapy as compared with external beam radiation among patients with recurrence after surgical resection. When soft-tissue sarcomas recur in a previously irradiated area, further external beam radiation generally is not possible; therefore, brachytherapy allows a radiotherapeutic alternative in an attempt to reduce the risk of further local recurrence. Recommendations for patient selection, the total dose of radiation, and the radiation dose-rate are outlined. Standard grading systems for response, symptoms, and severity of complications should be used.

AB - Radiation is used to reduce potential risk of local recurrence from microscopic residual disease after surgical resection. Brachytherapy is a clinically established means of providing radiation for soft-tissue sarcomas that recur after surgical resection alone or surgical resection and radiation. Although the total dose of radiation that is prescribed is approximately the same for patients undergoing external beam radiation or brachytherapy, the radiobiologic characteristics of brachytherapy, based on the inverse-square law, provide higher doses of radiation to the surgical bed. This provides a theoretical advantage for the use of brachytherapy as compared with external beam radiation among patients with recurrence after surgical resection. When soft-tissue sarcomas recur in a previously irradiated area, further external beam radiation generally is not possible; therefore, brachytherapy allows a radiotherapeutic alternative in an attempt to reduce the risk of further local recurrence. Recommendations for patient selection, the total dose of radiation, and the radiation dose-rate are outlined. Standard grading systems for response, symptoms, and severity of complications should be used.

UR - http://www.scopus.com/inward/record.url?scp=0036164674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036164674&partnerID=8YFLogxK

U2 - 10.1097/00000421-200202000-00002

DO - 10.1097/00000421-200202000-00002

M3 - Article

VL - 25

SP - 9

EP - 15

JO - American Journal of Clinical Oncology

JF - American Journal of Clinical Oncology

SN - 0277-3732

IS - 1

ER -